BCRX - BioCryst Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5376.17M
Enterprise Value 3367.01M
Trailing P/E N/A
Forward P/E 1-2.89
PEG Ratio (5 yr expected) 1-0.31
Price/Sales (ttm)16.67
Price/Book (mrq)16.72
Enterprise Value/Revenue 316.26
Enterprise Value/EBITDA 6-3.89

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-421.18%

Management Effectiveness

Return on Assets (ttm)-39.90%
Return on Equity (ttm)-251.96%

Income Statement

Revenue (ttm)22.56M
Revenue Per Share (ttm)0.21
Quarterly Revenue Growth (yoy)48.10%
Gross Profit (ttm)-64.71M
EBITDA -94.28M
Net Income Avi to Common (ttm)-106.53M
Diluted EPS (ttm)-1.0040
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)107.56M
Total Cash Per Share (mrq)0.98
Total Debt (mrq)84.06M
Total Debt/Equity (mrq)373.47
Current Ratio (mrq)1.77
Book Value Per Share (mrq)0.20

Cash Flow Statement

Operating Cash Flow (ttm)-99.91M
Levered Free Cash Flow (ttm)-55.84M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.02
52-Week Change 3-40.50%
S&P500 52-Week Change 33.46%
52 Week High 39.9500
52 Week Low 33.1000
50-Day Moving Average 37.6037
200-Day Moving Average 38.2396

Share Statistics

Avg Vol (3 month) 31.55M
Avg Vol (10 day) 36.02M
Shares Outstanding 5110.31M
Float 66.35M
% Held by Insiders 11.04%
% Held by Institutions 193.64%
Shares Short (Apr 30, 2019) 410.52M
Short Ratio (Apr 30, 2019) 410.61
Short % of Float (Apr 30, 2019) 412.88%
Short % of Shares Outstanding (Apr 30, 2019) 49.54%
Shares Short (prior month Mar 29, 2019) 410.72M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A